NY Times Says We’ve Got the Roadmap for Living Longer
Can We Live to 200?, a recent New York Times Article, provides a roadmap with the innovations that are currently being explored that have the potential to massively extend the average human life expectancy. From mRNA Vaccines that are currently being used to fight COVID-19, to nano-scale robots that could help our bodies fight cancer in the next hundred years, advancements in the sciences are progressing rapidly.
A looming threat to baby boomers is cognitive decline, most commonly, the Alzheimer’s epidemic. Alzheimer’s is the sixth most common cause of death in the US. Although Alzheimer’s risk goes up with age, there is much that can be done to work toward prevention. Together, scientists, philanthropists, and government institutions are in aggressive pursuit of a world without Alzheimer’s disease.
Experts agree that new approaches to Alzheimer’s therapies are needed, including noninvasive, drug-free solutions that meet today’s dynamically aging population. Scientific studies are focusing on drug discoveries to inhibit plaque build-up as well as noninvasive therapies like 40Hz light and 40Hz sound to entrain healthy brain function. “Shining a Light on Alzheimer’s,” the author of the NYTimes article writes, “Devices that stimulate the brain using specific frequencies of light and sound might help treat Alzheimer’s disease and other causes of cognitive decline.”
Healthy brains feature rhythmic patterns, or brain waves, that oscillate at a range of 30 to 100 Hz, and are associated with higher-order cognitive function. These frequencies are known to decrease in the brains of people with Alzheimer’s. 40Hz light stimulation is known to entrain healthy brain rhythms leading to improved mental acuity, memory, and attention. Rejuvenated healthy brain rhythm boosts the response of microglia, naturally existing cells that clear harmful debris such as amyloid plaque in the brain.
MIT researchers have shown that using LED lights flickering at a specific 40Hz frequency can substantially reduce the beta amyloid plaques seen in Alzheimer’s disease. After an hour of exposure at 40Hz, the researchers found a 40 to 50% reduction in the levels of beta amyloid proteins in the hippocampus.
Today, BEACON40® light systems are available for home and office use. Institutional product lines are also available. BEACON40® lights are safe, silent, and noninvasive. They’re designed to deliver nurturing lights that fade into the background with precision engineering that meets caregiver needs. Note: BEACON40 is not a medical device and is not intended as a treatment for Alzheimer’s disease.
Each day, advances in science and technology are increasing longevity and enhancing the quality of life for millions of people. As a health and wellness company, grounded in technology solutions, our pride lies in fast-tracking promising research into a safe and non invasive light system for at-home use. Our aim is to deliver hope and help to those who are battling cognitive decline, maintaining brain health, or looking to be proactive with preventative therapy.